Life Healthcare sees 7.8% revenue growth
Loading player...
GUEST - Peter Wharton-Hood – Life Healthcare CEO
Life Healthcare Group reported strong operating performance for the six-month period to 31 March 2024, growing group revenue by 7.8% to R11.7 billion.
KEY HIGHLIGHTS:
· Conclusion of sale of Alliance Medical Group
· Revenue from continuing operations up 7.8%
· Southern Africa acute PPD growth up 2.7%
· Southern Africa acute revenue up 5.9%
· Conclusion of Fresenius Medical Care acquisition
· Life Molecular Imaging Neuraceq® dosage sales up by 74.4%
· Life Molecular Imaging revenue up 77.5% · Interim Dividend of 19 cents up 11.8%
Life Healthcare Group reported strong operating performance for the six-month period to 31 March 2024, growing group revenue by 7.8% to R11.7 billion.
KEY HIGHLIGHTS:
· Conclusion of sale of Alliance Medical Group
· Revenue from continuing operations up 7.8%
· Southern Africa acute PPD growth up 2.7%
· Southern Africa acute revenue up 5.9%
· Conclusion of Fresenius Medical Care acquisition
· Life Molecular Imaging Neuraceq® dosage sales up by 74.4%
· Life Molecular Imaging revenue up 77.5% · Interim Dividend of 19 cents up 11.8%
